Dr. Steve Hajioff is a distinguished clinician renowned for his innovations and thought leadership in clinical data science, healthcare technology, public health, and health policy. With a focus on enacting positive change, he has significant experience in enhancing organizational capacity and capability. Dr. Hajioff has held extensive board-level roles, managing budgets, and leading diverse, complex teams across public, private, and voluntary sectors both locally and internationally.
Join Dr. Hajioff and producer David on a medical journey, exploring PFAK research, AI, psychedelic therapy, preventive medicine, and global healthcare, notably contrasting UK, US, and Canadian systems. Delve into longevity, dietary trends, cancer prevention, gut microbiome studies, artificial sweeteners, melatonin use, and supplement industries. Discover innovations like Neuralink, glucose monitoring, sensory organ transplants, and tackle genetic disease management, biotechnological developments, medical ethics, and pharmaceutical intricacies in this in-depth exploration of varied medical fields.
27 Rouge💄 is a reader-supported publication. My independence as a writer, podcaster, and idea sharer affords me the freedom to write, speak, and produce unencumbered. If you find my work to be engaging and useful, please share 27 Rouge and consider becoming a paid subscriber or making a one-off or recurring donation. You won’t regret it. Or maybe you will :D
Medical Frontiers: AI, Psychedelics, Longevity, and US vs. UK Healthcare | Dr. Steve Hajioff